Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
Journal: Molecular cancer research : MCR
Published: September 10, 2020
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.
Journal: Cancer metastasis reviews
Published: September 04, 2020
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.
Journal: Cancers
Published: June 13, 2019
Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer.
Journal: British journal of cancer
Published: February 18, 2017
Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations.
Journal: PloS one
Published: October 01, 2016
Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer.
Journal: Scientific reports
Published: September 09, 2016
A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.
Journal: Journal of ovarian research
Published: January 15, 2016
Polar biophenolics in sweet potato greens extract synergize to inhibit prostate cancer cell proliferation and in vivo tumor growth.
Journal: Carcinogenesis
Published: May 01, 2013
A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migration.
Journal: Carcinogenesis
Published: June 09, 2012
Last Updated: 09/26/2026